WBA - Walgreens Boots Alliance, Inc.

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Stockaholic, Apr 4, 2016.

  1. Money123

    Money123 Active Member

    Joined:
    Aug 16, 2017
    Messages:
    722
    Likes Received:
    125
    He said it a month ago or so.

    CVS and Walgreens both going up. Walgreens up today because of chart breaking Downtrend still should keep goon gup
     
  2. Money123

    Money123 Active Member

    Joined:
    Aug 16, 2017
    Messages:
    722
    Likes Received:
    125
    New news

    Analysts who follow Walgreens Boots Alliance Inc (WBA) on average expect it to rise 33.89% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns WBA an Analyst Ranking of 16, which means it ranks higher than 16 of stocks, based on data compiled by InvestorsObserver.
     
  3. rg7803

    rg7803 Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    614
    Likes Received:
    453

    Understand one thing: prices dont go up/down because charts are breaking downtrends, moving averages, price levels or what so ever.

    Charts simply do what they supose to do: record price evolution in time.

    And yes they are usefull. And yes again TA works. But not in the sense of most users use them. Charts dont predict future, they are not magic balls. They give you the confort of identifying the best buying/selling zones where odds will work best for you. Just that.
     
    Rayak likes this.
  4. Money123

    Money123 Active Member

    Joined:
    Aug 16, 2017
    Messages:
    722
    Likes Received:
    125
    I was up alot today so sold prob still going up.
     
  5. Money123

    Money123 Active Member

    Joined:
    Aug 16, 2017
    Messages:
    722
    Likes Received:
    125
    Billionaire Israel Englander Sold 70% of Millennium's Stake in Nvidia and Is Piling Into a Supercharged Dividend Stock With a Nearly 12% Yield WBA
     
  6. Rayak

    Rayak Active Member

    Joined:
    Jul 30, 2022
    Messages:
    224
    Likes Received:
    149
    WBA was over $37 in the spring of 2022, has been on a downward spiral ever since - now all the way down to $9 a share. So maybe it is oversold and a good buy?

    I have several sources that I use for analyst forecasts. I have chosen these over time for being more reputable than some of the others I've tried. Here is a summary of the analysts foecasts for WBA from my personal preferred sources:

    Source1:
    Strong Buy: 1
    Buy: 2
    Hold: 11
    Underperform: 2
    Sell: 2
    Overall rating: HOLD

    Source2:
    Strong Buy: 1
    Buy: 1
    Hold: 8
    Underperform: 4
    Sell: 0
    Overall rating: HOLD

    Source3:
    Strong Buy: 0
    Buy: 1
    Hold: 8
    Underperform: 7
    Sell: 1
    Overall rating: UNDERPERFORM

    Analysts ratings should be only one tool in the investors toolbox. Analysts are frequently wrong, and often biased. Sometimes they are even given incentives to alter their ratings.

    In two of the last four quarters that WBA has reported, they have LOST money.

    I'm providing the above information only for that reason: as information. I pulled this information on 11/29/2024 - so it is as up to date as I can find, as of that date.


     
  7. Money123

    Money123 Active Member

    Joined:
    Aug 16, 2017
    Messages:
    722
    Likes Received:
    125
    Nice analyst reviews

    May buy $WBA 9.00 bucks
     
  8. Money123

    Money123 Active Member

    Joined:
    Aug 16, 2017
    Messages:
    722
    Likes Received:
    125
    It's a buy now

    Sick Walgreens $WBA $147B in revenue vs. $8B market cap makes it a buy! The stock's down 90% from highs due to a negative bottom line in the last 2 years. They have a dividend yield of 11%, which I wouldn't be surprised if they cut to fund buybacks.
     
  9. Money123

    Money123 Active Member

    Joined:
    Aug 16, 2017
    Messages:
    722
    Likes Received:
    125
    Would have made 17 percent today. Going private. Walgreens Boots Alliance (WBA.O), opens new tab is in talks to sell itself to private equity firm Sycamore Partners, according to a person familiar with the matter, the latest attempt by the pharmacy chain operator to go private after a sharp slump in share value
     

Share This Page